Holen Sie sich die Stockscreener-App
3.09
5.10%
0.15
Handel nachbörslich:
3.07
-0.02
-0.65%
Schlusskurs vom Vortag:
$2.94
Offen:
$2.98
24-Stunden-Volumen:
1.00M
Relative Volume:
1.25
Marktkapitalisierung:
$306.46M
Einnahmen:
$69.56M
Nettoeinkommen (Verlust:
$-240.05M
KGV:
-1.0475
EPS:
-2.95
Netto-Cashflow:
$-121.90M
1W Leistung:
+17.05%
1M Leistung:
-1.90%
6M Leistung:
+91.93%
1J Leistung:
+8.80%
1-Tages-Spanne:
$2.95
$3.23
1-Wochen-Bereich:
$2.56
$3.23
52-Wochen-Spanne:
$1.05
$3.97
Adc Therapeutics Sa Stock (ADCT) Company Profile
Firmenname
Adc Therapeutics Sa
Sektor
Branche
Telefon
41 21 653 02 00
Adresse
BIOPOLE, EPALINGES
Vergleichen Sie ADCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
3.09 | 330.05M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-28 | Eingeleitet | Guggenheim | Buy |
| 2023-08-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-04-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-06 | Eingeleitet | CapitalOne | Overweight |
| 2022-11-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | Eingeleitet | Wolfe Research | Outperform |
| 2021-08-17 | Fortgesetzt | Jefferies | Buy |
| 2021-08-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Eingeleitet | Stifel | Hold |
| 2020-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-06-09 | Eingeleitet | BofA/Merrill | Buy |
| 2020-06-09 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten
ADC Therapeutics (NYSE:ADCT) Announces Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - BioSpace
ADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call Transcript - Insider Monkey
ADC Therapeutics 2025 Q2 Earnings Deeper Losses Amid Revenue Growth - AInvest
MACD Cross Could Confirm Trend in ADC Therapeutics SA2025 Biggest Moves & Real-Time Buy Signal Notifications - metal.it
ADC Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts - MSN
Transcript : ADC Therapeutics SA, Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
ADC Therapeutics SA reports results for the quarter ended June 30Earnings Summary - TradingView
ADC Therapeutics SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
ADC Therapeutics Reports Second Quarter 2025 Financial Results - TradingView
Can ADC Therapeutics SA weather a recessionConsistent Triple Digit Profits - mustnews.co.kr
Using data models to predict ADC Therapeutics SA stock movementPortfolio Positioning Strategy With Timing - Newser
How to recover losses in ADC Therapeutics SA stockSafe Entry Screening with Data Backed Analysis - Newser
Can volume confirm reversal in ADC Therapeutics SASwing Trade Timing with Daily Forecast - Newser
Will ADC Therapeutics SA stock go up soonWeekly Hot Stocks Based on Volume Flow - Newser
Will ADC Therapeutics SA continue its uptrendFree Value Investing Picks With Stability - Newser
Pattern recognition hints at ADC Therapeutics SA upsideAlpha Trade Flow With Risk Calibration - Newser
Earnings visualization tools for ADC Therapeutics SAFree Weekly Return Pick Forecast Reports - Newser
Is ADC Therapeutics SA reversing from oversold territoryRSI and MACD Signal Summary with Trends - Newser
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 - 富途牛牛
Bank of New York Mellon Corp Decreases Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World
What’s next for ADC Therapeutics SA stock pricePredictive Analytics for Equity Growth Potential - Newser
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
What makes ADC Therapeutics SA stock price move sharplySmart Trade Mapping with Entry Details - Newser
Chondrosarcoma Market: Epidemiology, Pipeline Products, Companies Working, Delveinsight Aadi Bioscience Inc, Acrotech Biopharma LLC, ADC Therapeutics SA, Advenchen Laboratories LLC, Alkermes Plc, As - Menafn
How strong is ADC Therapeutics SA company’s balance sheetCapitalize on emerging growth stocks - Jammu Links News
What is ADC Therapeutics SA company’s growth strategyGet alerts on high-potential stock breakouts - Jammu Links News
How volatile is ADC Therapeutics SA stock compared to the marketMaximize portfolio value with expert tips - Jammu Links News
Does ADC Therapeutics SA stock perform well during market downturnsGet daily updates on top-performing stocks - Jammu Links News
Should I hold or sell ADC Therapeutics SA stock in 2025Achieve rapid growth with smart investments - Jammu Links News
What institutional investors are buying ADC Therapeutics SA stockConsistent triple-digit returns - Jammu Links News
What is the dividend policy of ADC Therapeutics SA stockUnlock exclusive trading strategies for gains - Jammu Links News
ADC Therapeutics (ADCT) to Release Quarterly Earnings on Tuesday - Defense World
Is ADC Therapeutics SA stock overvalued or undervaluedGet daily updates on promising stocks - Jammu Links News
Why ADC Therapeutics SA stock attracts strong analyst attentionEquity Forecast with Predictive AI Screener - Newser
How does ADC Therapeutics SA generate profit in a changing economyLightning-fast growth - Jammu Links News
What are the latest earnings results for ADC Therapeutics SAInvest smarter with actionable trading signals - Jammu Links News
What are ADC Therapeutics SA company’s key revenue driversUnlock high-yield investment opportunities - Jammu Links News
What is the risk reward ratio of investing in ADC Therapeutics SA stockAchieve rapid capital gains with smart investing - Jammu Links News
Earnings Beat: ADC Therapeutics SA (NYSE:ADCT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - 富途牛牛
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Adc Therapeutics shares rise 11.52% after-hours after granting options to new employees. - AInvest
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - StreetInsider
ADC Therapeutics Makes Grants To New Employees Under Inducement Plan - Barchart.com
ADC Therapeutics SA expected to post a loss of 47 cents a shareEarnings Preview - TradingView
How ADC Therapeutics SA stock performs during market volatilityTarget Return Focused Trade Insights Shared - metal.it
ADC Therapeutics SA Price Targets Raised After ReboundWeekly Watchlist of High Movers Released - metal.it
Finanzdaten der Adc Therapeutics Sa-Aktie (ADCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):